Ilkka A Ojanperä (Ilkka Ojanperä)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Intimate Partner Violence

Polycyclic Aromatic Hydrocarbons

Major Depressive Disorder

Top Venues

Drug testing and analysis

International journal of legal medicine

Journal of analytical toxicology

Addiction (Abingdon, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Mariottini, Margareeta Häkkinen, Pirkko Kriikku, Ilkka A Ojanperä
Buprenorphine deaths confirmed by toxicology reveal a low proportion of opioid agonist treatment before death in Finland. International journal of legal medicine (2024)
Pirkko Kriikku, Aino Kankaanpää, Teemu Gunnar, Ilkka A Ojanperä
Comparison of poisoning deaths with wastewater-based consumption estimates and assessment of fatal toxicity for amphetamine-type stimulant drugs. Drug testing and analysis (2023)
Pirkko Kriikku, Ilkka A Ojanperä
Fatal concentrations of antidepressant and antipsychotic drugs in post-mortem femoral blood. Journal of analytical toxicology (2023)
Pirkko Kriikku, Eija A Kalso, Ilkka A Ojanperä
Post-mortem oxycodone blood concentrations of hospitalized cancer and surgery patients compared with fatal poisonings. International journal of legal medicine 136 (6) (2022)
Claudia Mariottini, Pirkko Kriikku, Ilkka A Ojanperä
Investigation of buprenorphine-related deaths using urinary metabolite concentrations. Drug testing and analysis 14 (10) (2022)
Claudia Mariottini, Merja Gergov, Ilkka A Ojanperä
Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry. Drug testing and analysis 13 (9) (2021)
Claudia Mariottini, Ilkka A Ojanperä, Pirkko Kriikku
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland. Drug testing and analysis 13 (4) (2020)
Terhi N Keltanen, Pertti K Heikman, Leea H Muhonen, Teemu O Gunnar, Ilkka A Ojanperä
Enzymatic assay for urine lactose in the assessment of recent intravenous abuse of buprenorphine. Drug testing and analysis 11 (9) (2019)
Raimo A Ketola, Ilkka A Ojanperä
Summary statistics for drug concentrations in post-mortem femoral blood representing all causes of death. Drug testing and analysis 11 (9) (2019)
Jari K Haukka, Pirkko Kriikku, Claudia Mariottini, Timo Partonen, Ilkka A Ojanperä
Non-medical use of psychoactive prescription drugs is associated with fatal poisoning. Addiction (Abingdon, England) 113 (3) (2017)